首页> 外国专利> THE CONTROLLED RELEASED PHARMACEUTICAL COMPSITIONS OF UDENAFIL FOR SUSTAINED RELEASE PROPERTY

THE CONTROLLED RELEASED PHARMACEUTICAL COMPSITIONS OF UDENAFIL FOR SUSTAINED RELEASE PROPERTY

机译:乌地那非控释药物的控释药物成分

摘要

PURPOSE: A controller release composition for manufacturing sustained release formulation containing udenafil is provided to freely control release time of drug. CONSTITUTION: A controller release composition for manufacturing sustained release formulation contains: udenafil and pharmaceutically acceptable sa a solubility adjusting agent of citric acid, malic acid, adipic acid, ascorbic acid, succinic acid, or tartaric acid; an adsorber of silicon dioxide, calcium silicate, talc, or aluminum magnesium metasilicate; and a hydrophilic polymer of hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropylmethylcellulose, polyethylene oxide, xanthangum, guar gum, locust bean gum, or sodium alginate. The composition additionally contains a pore former, expanding agent, diluting agent, and lubricant.
机译:目的:提供一种用于制造包含udenafil的缓释制剂的控制释放组合物,以自由控制药物的释放时间。构成:用于制造缓释制剂的控制释放组合物,包含:乌地那非和药学上可接受的盐;柠檬酸,苹果酸,己二酸,抗坏血酸,琥珀酸或酒石酸的溶解度调节剂;二氧化硅,硅酸钙,滑石粉或偏硅酸铝镁的吸附剂;以及羟乙基纤维素,羟丙基纤维素,羟丙基甲基纤维素,聚环氧乙烷,黄原胶,瓜尔豆胶,刺槐豆胶或海藻酸钠的亲水性聚合物。该组合物还包含成孔剂,膨胀剂,稀释剂和润滑剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号